Download PDF
Dtsch Med Wochenschr 2006; 131(28/29): 1609-1613
DOI: 10.1055/s-2006-947806
Übersicht | Review article
Dermatologie, Transplantationsmedizin
© Georg Thieme Verlag KG Stuttgart · New York

Hauttumore nach Organtransplantation

Skin cancer after organ transplantationM. Hackethal1 , C. Ulrich1 , E. Stockfleth1
  • 1Klinik für Dermatologie, Venerologie und Allergologie, Charité, Humboldt-Universität Berlin
Further Information

Publication History

eingereicht: 8.3.2006

akzeptiert: 4.5.2006

Publication Date:
06 July 2006 (online)

Also available at
    Permissions and Reprints

Schlüsselwörter

Immunsuppression - Organtransplantation - Malignome der Haut - Flächenkarzinose - nicht-melanozytäre Hauttumoren - aktinische Keratose

Key words

immunosuppression - transplantation - skin cancer - field cancerization - nonmelanoma skin cancer - actinic keratosis

Literatur

  • 1 Berg C, Otley C C. Skin cancer in organ tranplant recipients: Epidemiology, pathogenesis, and management.  J Am Acad Dermatol. 2002;  47 1-17
    Google Scholar
  • 2 Brown V L, Atkins C L, Ghali L, Cerio R, Harwood C A, Proby C M. Safety and efficacy of 5 % imiquimod cream for the treatment of skin dysplasia in high-risk renal transplant recipients.  Arch Dermatol. 2005;  141 985-993
    Google Scholar
  • 3 Buell J F, Trofe J, Hanaway M J. et al . Immunosuppression and Merkel cell cancer.  Transplant Proc. 2002;  34 1780-1781
    Google Scholar
  • 4 Capello D, Rossi D, Gaidano G. Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis.  Hematol Oncol. 2005;  23 61-67
    Google Scholar
  • 5 Carucci J A, Martinez J C, Zeitouni N C. et al . In-transit metastasis from primary cutaneous squamous cell carcinoma in organ transplant recipients and nonimmunosuppressed patients.  Dermatol Surg. 2004;  30 651-655
    Google Scholar
  • 6 Clayton A S, Stasko T. Treatment of nonmelanoma skin cancer in organ transplant recipients.  J Am Acad Dermatol. 2003;  49 413-416
    Google Scholar
  • 7 O’Donovan P, Perrett C M, Zhang X. et al . Azathioprine and UVA light generate mutagenic oxidative DNA damage.  Science. 2005;  309 1871-1874
    Google Scholar
  • 8 Dragieva G, Hafner J, Dummer R. et al . Topical photodynamic therapy in the treatment of actinic keratoses and BowenŽs disease in transplant recipients.  Transplantation. 2004;  77 115-121
    Google Scholar
  • 9 Euvrard S, Ulrich C, Lefrancois N. Immunosuppressants and skin cancer in transplant patients..  Dermatol Surg. 2004;  30 628-633
    Google Scholar
  • 10 Fortina A B, Piaserico S, Caforio A L. et al . Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients.  Arch Dermatol. 2004;  140 1079-1085
    Google Scholar
  • 11 Fritsch C. et al . Photodynamic Diagnosis and Therapy in Dermatology.  Skin Pharmacol Appl Skin Physiol. 1998;  11 358-373
    Google Scholar
  • 12 Gerlini G, Romagnoli P, Pimpinelli N. Skin cancer and immunosuppression.  Crit Rev Oncol Hematol. 2005;  56 127-136
    Google Scholar
  • 13 de Graaf Y G. et al . Photodynamic therapy does not prevent cutaneous squamous-cell carcinoma in organ-transplant recipients.  J Invest Dermatol. 2006;  126 569-574
    Google Scholar
  • 14 Jorizzo J L. Current and novel treatment options for actinic keratosis.  J Cutan Med Surg. 2004;  8 13-21
    Google Scholar
  • 15 Kanitakis J, Alhaj-Ibrahim L, Euvrard S, Claudy A. Basal cell carcinomas in solid organ transplant recipients.  Arch Dermatol. 2003;  139 1133-1137
    Google Scholar
  • 16 Karagas M R, Cushing G L, Greenberg E R. et al . Non-melanoma skin cancers and glucocorticoid therapy.  Br J Cancer. 2001;  85 683-686
    Google Scholar
  • 17 Kovach B T, Sams H H, Stasko T. Systemic strategies for chemoprevention of skin cancers in transplant recipients.  Clin Transplant. 2005; DOI: 10.1111/j.13990012.2005.00412.x; 
    Google Scholar
  • 18 Kovach B T, Stasko T. Use of topical immunmodulators in organ transplant recipients.  Dermatol Ther. 2005;  18 19-27
    Google Scholar
  • 19 Leitlinien der Deutschen Dermatologischen Gesellschaft (DDG) AWMF-Leitlinien-Register Nr. 013/041 .Aktinische Keratose. www.uni-duesseldorf.de/AWMF/ll/ll_derma.htm. 
    Google Scholar
  • 20 Lok C, Viseux V, Denoeux J P, Bagot M. Post-transplant T-cell-lymphomas.  Crit Rev Oncol Hematol. 2005;  56 137-145
    Google Scholar
  • 21 Otley C C, Berg D, Ulrich C. et al . Reduction of immunosuppression for transplant-associated skin cancer: expert consensus survey.  Br J Dermatol. 2006;  154 395-400
    Google Scholar
  • 22 Parrish J A. Immunosuppression, skin cancer, and ultraviolet A radiation.  N Engl J Med. 2005;  353 2712-2713
    Google Scholar
  • 23 Poulsen M. Merkel-cell carcinoma of the skin.  Lancet Oncol. 2004;  5 593-599
    Google Scholar
  • 24 Rao J. Let There Be Light: An overview of cutaneous photodynamic therapy. www.departmentofmedicine.ualberta.ca/mgr_09-10-04.htm
    Google Scholar
  • 25 Rivers J K, Arlette J, Shear N, Guenther N, Carey W, Poulin Y. Topical treatment of actinic keratoses with 3 % diclofenac in 2,5 % hyaluron gel.  Br J Dermatol. 2002;  146 94-100
    Google Scholar
  • 26 Shuttleworth D, Marks R, Griffin P J, Salaman J R. Epidermal dysplasia and cyclosporine therapy in renal transplant patients: a comparison with azathioprine.  Br J Dermatol. 1989;  120 551-554
    Google Scholar
  • 27 Smith K J, Germain M, Skelton H. Squamous cell carcinoma in situ (BowenŽs disease) in renal transplant patients treated with 5 % imiquimod and 5 % 5-Fluorouracil therapy.  Dermatol Surg. 2001;  27 561-564
    Google Scholar
  • 28 Stallone G, Schena A, Infante B. et al . Sirolimus for KaposiŽs sarcoma in renal-transplant recipients.  N Engl J Med. 2005;  352 1317-1323
    Google Scholar
  • 29 Stockfleth E, Christophers E, Benninghoff B, Sterry W. Low incidence of new actinic keratoses after topical 5 % imiquimod cream treatment: a long-term follow-up study.  Arch Dermatol. 2004;  140 1542
    Google Scholar
  • 30 Stockfleth E, Meyer T, Benninghoff B. et al . A randomized, double blind, vehicle-controlled study to assess 5 % imiquimod cream for the treatment of multiple actinic keratoses.  Arch Dermatol. 2002;  138 1498-1502
    Google Scholar
  • 31 Testerman T L, Gerster J F, Imbertson L M. et al . Cytokine induction by the immunmodulators imiquimod and S-27 609.  J Leukoc Biol. 1995;  58 365-372
    Google Scholar
  • 32 Ulrich C, Christophers E, Sterry W, Meyer T, Stockfleth E. Hauterkrankungen bei organtransplantierten Patienten.  Hautarzt. 2002;  53 524-533
    Google Scholar
  • 33 Ulrich C, Schmook T, Sachse M M, Sterry W, Stockfleth E. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients (Review).  Dermatol Surg. 2004;  30 622-627
    Google Scholar
  • 34 Ulrich C, Stockfleth E. UV light, azathioprine and skin cancer in organ transplant patients - do we have the answer?.  Nephrol Dial Transplant. 2006;  in press
    Google Scholar
  • 35 Veness M J, Quinn D I, Ong C S. et al . Aggressive cutaneous malignancies following cardiothoracic transplantation.  Cancer. 1999;  85 1758-1764
    Google Scholar
  • 36 Vidal D, Alomar A. Efficacy of imiquimod 5 % cream for basal cell carcinoma in transplant patients.  Clin Exp Dermatol. 2004;  29 237-239
    Google Scholar
  • 37 Wang K, Zhang H, Li Y. et al . Efficacy of mycophenolate mofetil versus azathioprine after renal transplantation: a systematic review.  Transplant Proc. 2004;  36 2071-2072
    Google Scholar

Professor Dr. med. Eggert Stockfleth

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsmedizin Berlin

Schumannstraße 20-21

10117 Berlin

Phone: 030/450518266

Fax: 030/450518966

Email: Eggert.Stockfleth@charite.de